A Real-time, Contextual Intervention Using PDAs to Reduce Marijuana Use in Youth
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Boston Children's Hospital
- Enrollment
- 70
- Locations
- 2
- Primary Endpoint
- Marijuana desire
Study Overview
Brief Summary
The purpose of this study is to further develop and test the Momentary Self-Monitoring and Feedback + Motivational Enhancement Therapy (MOMENT) intervention, a real-time, contextual intervention to reduce marijuana use among primary care patients.
Detailed Description
This study proposes a pilot randomized trial to further develop and test the Momentary Self-Monitoring and Feedback + Motivational Enhancement Therapy (MOMENT) intervention, a real-time, contextual intervention to reduce marijuana use over three months in 15-to-24-year-old primary care patients who use frequently. We will randomize youth to one of two arms (goal 30 per arm completing 3-month follow-up): 1) MOMENT (MET + momentary self-monitoring + context-dependent feedback), or 2) MET-only. The two study arms will permit evaluation of the contributions of the self-monitoring and feedback components of the intervention above-and-beyond the MET and directly test the influence of the intervention on the link between momentary context and marijuana-related outcomes.
The specific aims of the study are
Specific Aim 1: Continued Feasibility Evaluation. In our preliminary work, we demonstrated that 1) youth perceive MOMENT to be easy to understand, comfortable, motivating, and helpful in reducing their marijuana use, 2) we can recruit 4 participants/month (minimum rate for the proposed study), and 3) we can successfully implement a MOMENT intervention study in the proposed recruitment sites. Based on this work, we have identified additional areas of feasibility on which to focus in the proposed study. Specifically, we aim to achieve:
1a. A signal response rate of at least 70% during each of three periods of momentary data collection - baseline, intervention, and 3-month follow-up.
1b. A diary response rate of at least 70% during each momentary data collection period
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Investigator)
Eligibility Criteria
- Ages
- 15 Years to 24 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Male or female between the ages of 15-24 years
- •Patient of the Boston Children's Hospital Adolescent/Young Adult Medicine Clinic or Martha Elliot Health Center Adolescent Clinic
- •Ability to read and understand English
Exclusion Criteria
- •Medically or emotionally unstable, intoxicated or "high,", or otherwise unable to give consent at the time of their appointment
- •Have previously participated in this study
- •Does not meet the above inclusion criteria
Arms & Interventions
MET only
Motivational Enhancement Therapy only
Intervention: MET (Behavioral)
MOMENT
The full MOMENT intervention: Motivational Enhancement Therapy + momentary and daily mobile self-monitoring + motivational feedback messages prompting participants to consider their individualized coping strategies to avoid using marijuana
Intervention: MOMENT (Behavioral)
MOMENT
The full MOMENT intervention: Motivational Enhancement Therapy + momentary and daily mobile self-monitoring + motivational feedback messages prompting participants to consider their individualized coping strategies to avoid using marijuana
Intervention: MET (Behavioral)
Outcomes
Primary Outcomes
Marijuana desire
Time Frame: 3 months
Desire to use marijuana when in top-3 trigger context
Marijuana use following trigger exposure
Time Frame: 3 months
Marijuana use following exposure to top-3 trigger context
Motivation to reduce marijuana use
Time Frame: 3 months
Daily score on 3 scales - readiness to reduce marijuana use, importance of reducing use, and confidence in ability to reduce use
Frequency of marijuana use
Time Frame: 3 months
Marijuana use events/day
Percent days abstinent
Time Frame: 3 months
30-day percent days abstinent from marijuana use
Secondary Outcomes
No secondary outcomes reported
Investigators
Lydia Shrier
Attending Physician, Adolescent Medicine
Boston Children's Hospital
